- Home
- SYY vs RVMD Comparison
SYY vs RVMD Comparison
Compare SYY & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SYY | RVMD |
|---|---|---|
| Founded | 1969 | 2014 |
| Country | United States | United States |
| Employees | N/A | 883 |
| Industry | Food Distributors | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 35.1B | 30.1B |
| IPO Year | 2003 | N/A |
Fundamental Metrics
Financial Performance| Metric | SYY | RVMD |
|---|---|---|
| Price | $80.06 | $150.05 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 13 | 19 |
| Target Price | $87.62 | ★ $140.84 |
| AVG Volume (30 Days) | ★ 2.8M | 2.5M |
| Earning Date | 04-28-2026 | 05-06-2026 |
| Dividend Yield | ★ 2.97% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.51 | N/A |
| Revenue | ★ $81,370,000,000.00 | N/A |
| Revenue This Year | $4.83 | N/A |
| Revenue Next Year | $4.96 | $533.02 |
| P/E Ratio | $31.29 | ★ N/A |
| Revenue Growth | ★ 3.20 | N/A |
| 52 Week Low | $68.19 | $34.00 |
| 52 Week High | $91.85 | $166.50 |
Technical Indicators
Market Signals| Indicator | SYY | RVMD |
|---|---|---|
| Relative Strength Index (RSI) | 68.03 | 52.20 |
| Support Level | $72.04 | $141.00 |
| Resistance Level | $83.07 | $152.38 |
| Average True Range (ATR) | 1.51 | 6.26 |
| MACD | 0.55 | -1.78 |
| Stochastic Oscillator | 99.72 | 34.56 |
Price Performance
Historical ComparisonAbout SYY Sysco Corporation
Sysco is the largest US foodservice distributor with 18% share of the highly fragmented $377 billion domestic market. It distributes roughly 500,000 food and nonfood products to restaurants (60% of fiscal 2025 revenue), education and government buildings (8%), healthcare facilities (8%), travel and leisure (7%), and other locations (17%) where individuals consume away-from-home meals. In fiscal 2025, 70% of the firm's revenue was derived from its US foodservice operations, while its international (18%), quick-service logistics (10%), and other (2%) segments contributed the rest.
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.